| Application no. and date | 13720714.8 (espacenet) (Federated) (European Patent Register), 20130425 | | Patent/reg. no. and date | DK/EP 2841456, 20180613 | | Publication date | 20150304 | | Priority no. and date | US 201261639637 P, 20120427 | | EP pub. no. and date |
EP 2841456 20150304 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé, 2880 Bagsværd, DK,
Amgen Inc., One Amgen Center Drive
Thousand Oaks, California 91320-1799, US | | Applicant ref. no. | BBS109239EPDK | | Inventor | ANDERSEN, Mette, Dahl, c/o Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK,
DANTZLER, Jeff, 14012 Wayne Pl. N.
Seattle, WA 98133, US,
ARMITAGE, Richard, J., 5840 Packard Lane
Bainbridge Island, WA 98110, US,
CLARK, Rutilio, 5335 Old Mill Road NE
Bainbridge Island, WA 98110, US | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | C07K 16/28 (2006.01) | | Title | HUMAN CD30-LIGAND-ANTIGENBINDENDE PROTEINER | | Int. application no. | US2013038135 | | Int. publication no. | WO2013163377 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
